drugset / Trial / NCT01088997
Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn
Terminated
12 enrolled
Children's Hospital of Philadelphia
American Medical Association · collabBedford Pharmaceuticals · collabThrasher Research Fund · collabUniversity of Pennsylvania · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this pilot study is to determine a safe dose of milrinone to use in a larger study of babies with persistent pulmonary hypertension of the newborn (PPHN).
Timeline
- Start
- 2010-06
- Primary completion
- 2013-02
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Milrinone | Small molecule | 0.2 ug/kg | Intravenous |
| Subject | Milrinone | Small molecule | 0.5 ug/kg | Intravenous |